ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Soft, Degradable, and Magnetic Microcarriers for Encapsulation and Guided Transport of Drugs and 3D Spheroids.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Soft microcarriers hold great potential for biomedical applications, yet their translation is limited by the lack of controlled degradation, restricted capacity for co-encapsulation of therapeutic and cellular cargos, long-term biocompatibility, and scalable production challenges. Here, we introduce a new concept of discrete, degradable hydrogel microcarriers, produced via droplet-based microfluidics and UV photopolymerization, designed to integrate these properties. These soft microcarriers enable co-encapsulation of multiple species, including magnetic particles, drugs, and living cell spheroids, while allowing precise motion control over complex trajectories using external gradient magnetic fields. Their tunable degradation under physiological conditions ensures transient stability, controlled navigation, and safe clearance. This approach provides spatiotemporal control over cargo transport and release, enabling the microcarriers to function as systems with a controllable lifecycle. These multifunctional microcarriers represent a versatile platform for tissue engineering, minimally invasive therapies, and diagnostic monitoring, enhanced by the precise in situ navigation option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.